has been cited by the following article(s):
[1]
|
Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity
Current Oncology Reports,
2023
DOI:10.1007/s11912-023-01434-0
|
|
|
[2]
|
Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity
Current Oncology Reports,
2023
DOI:10.1007/s11912-023-01434-0
|
|
|
[3]
|
HER2-Targeted Antibody–Drug Conjugates Display Potent Antitumor Activities in Preclinical Extramammary Paget’s Disease Models: In Vivo and Immunohistochemical Analyses
Cancers,
2022
DOI:10.3390/cancers14143519
|
|
|
[4]
|
Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node‑metastatic penoscrotal extramammary Paget's disease
Oncology Letters,
2019
DOI:10.3892/ol.2019.9930
|
|
|